A commonly described but poorly understood sequelae of hypertension is microvascular coronary disease. This problem may present in patients with chest pain and no evidence of obstruction on ...

The CardiAMP autologous cell therapy is delivered during ... The cell therapy is designed to promote microvascular repair through enhanced capillary density and reduced fibrosis, both of which ...

A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 participants in a ...

Investigators recently uncovered key insights into newly defined rejection entities in kidney transplantation that may offer improved patient risk categorization post-transplant. The research will ...

During the surgery, microvascular surgeons take a tissue ... she was among the first patients to receive autologous tissue flap reconstructive surgery from Dr. Nagel at Bozeman Health.

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

The heterogeneous clinical presentation of graft microvascular inflammation poses a major challenge to successful kidney transplantation. The effect of microvascular inflammation on allograft ...

Ribrecabtagene autoleucel is an autologous anti-BCMA CAR-T therapy that utilizes a humanized single-domain antibody as the antigen binding domain and lentivirus as a vector. DRL-1801 for the ...

The CardiAMP autologous cell therapy is delivered during a standard minimally invasive catheter-based procedure. Patients are typically discharged after an overnight stay. The cell therapy is designed ...